Bacteremia due to Citrobacter species: Significance of primary intraabdominal infection

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 543-549

  Shih, Chiang Ching ^a   Chen, Yee Chun ^c   Chang, Shan Chwen ^b   Luh, Kwen Tay ^c   Hsieh, Wei Chuan ^c  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE;

ABDOMINAL INFECTION; ABDOMINAL TUMOR; ARTICLE; BACTEREMIA; CHOLELITHIASIS; CITROBACTER; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPOTHERMIA; LUNG; MALE; OLIGURIA; PERITONEAL CAVITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; THROMBOCYTOPENIA; UREMIA; URINARY TRACT;

EID: 0029833750     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.543     Document Type: Article

References (27)

1. Lipsky BA, Hook EW III, Smith AA, Plorde JJ. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis 1980;2:746-60.
2. Samonis G, Anaissie E, Elting L, Bodey GP. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis 1991;10:479-85.
3. Drelichman V, Band JD. Bacteremias due to Citrobacter diversus and Citrobacter freundii: incidence, risk factors, and clinical outcome. Arch Intern Med 1985;145:1808-10.
4. Hodges GR, Degener CE, Barnes WG. Clinical significance of Citrobacter isolates. Am J Clin Pathol 1978;70:37-40.
5. Holmes B, King A, Phillips I, Lapage SP. Sensitivity of Citrobacter freundii and Citrobacter koseri to cephalosporins and penicillins. J Clin Pathol 1974;27:729-33.
6. Madrazo A, Geiger J, Lauter CB. Citrobacter diversus at Grace Hospital, Detroit, Michigan. Am J Med Sci 1975;270:497-501.
7. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
8. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
9. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial disk susceptibility tests: approved standard. NCCLS document no. M2-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1984.
10. Madrazo A, Henderson MD, Baker L, Vaitkevicius VK, Lauter CB. Massive empyema due to Citrobacter diversus. Chest 1975;68:104-6.
11. Roselle GA, Watanakunakorn C. Polymicrobial bacteremia. JAMA 1979;242:2411-3.
12. Parry MF, Hutchinson JH, Brown NA, Wu C-H, Estreller L. Gram-negative sepsis in neonates: a nursery outbreak due to hand carriage of Citrobacter diversus. Pediatrics 1980;65:1105-9.
13. Grant MD, Horowitz HI, Lorian V. Gangrenous ulcer and septicemia due to Citrobacter. N Engl J Med 1969;280:1286-7.
14. Jones SR, Ragsdale AR, Kutscher E, Sanford JP. Clinical and bacteriologic observations and a recently recognized species of Enterobacteriaceae, Citrobacter diversus. J Infect Dis 1973;128:563-5.
15. Lew PD, Baker AS, Kunz LJ, Moellering RC Jr. Intra-abdominal Citrobacter infections: association with biliary or upper gastrointestinal source. Surgery 1984;95:398-403.
16. Bartlett JG. Intra-abdominal sepsis. Med Clin North Am 1995;79:599-617.
17. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology, and ecology in 612 patients. Am J Med 1980;68:332-43.
18. Kiani D, Quinn EL, Burch KH, Madhavan T, Saravolatz LD, Neblett TR. The increasing importance of polymicrobial bacteremia. JAMA 1979;242:1044-7.
19. Elting LS, Bodey GP, Fainstein V. Polymicrobial septicemia in the cancer patient. Medicine (Baltimore) 1986;65:218-25.
20. DuPont HL, Spink WW. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota medical center, 1958-1966. Medicine (Baltimore) 1969;48:307-32.
21. Watanakunakorn C, Perni SC. Proteus mirabilis bacteremia: a review of 176 cases during 1980-1992. Scand J Infect Dis 1994;26:361-7.
22. Skerk V, Bobinac E, Popovic-Uroic T, Schönwald S. Istraživanje Klinićkolaboratorijskih parametara bakterijemije i sepse uzrokovane Escherichiom coli. Lijec Vjesn 1993;115:85-9.
23. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
24. Samonis G, Ho DH, Gooch GF, Rolston KVI, Bodey GP. In vitro susceptibility of Citrobacter species to various antimicrobial agents. Antimicrob Agents Chemother 1987;31:829-30.
25. Watanakunakorn C, Jura J. Klebsiella bacteremia: a review of 196 episodes during a decade (1980-1989). Scand J Infect Dis 1991;23:399-405.
26. Rello J, Quintana E, Mirelis B, Gurguí M, Net A, Prats G. Polymicrobial bacteremia in critically ill patients. Intensive Care Med 1993;19:22-5.
27. Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M. Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 1992;14:949-51.